What's breaking now, across thousands of outlets.
Management outlined a revised UK submission strategy and early named patient access plans for Ebstracel.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Chamonix cost cuts and refinancing delays tested management's outlook this quarter.
Cost cuts doubled adjusted EPS despite softer sales and streaming pressure.
The web infrastructure giant crushed third-quarter earnings estimates as it begins monetizing the incoming wave of autonomous AI agents.
Record billings and raised guidance point to strong AI-driven demand.
Management outlines a turnaround plan as profit improvement falls short of expectations.
Margins widened and debt nearly vanished as traffic kept climbing this quarter.